0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Dermatology | 
JAMA Dermatology Clinicopathological Challenge |  ONLINE FIRST
Tahmina Mahmood, BS; Mary Horner, MD; Alan Menter, MD
JAMA Dermatol. Published online January 21, 2015. doi:10.1001/jamadermatol.2014.4361

JAMA Dermatology | 
Case Report/Case Series |  ONLINE FIRST
Keshavamurthy Vinay, MD; Amrinder J. Kanwar, MD, FRCP; Ankit Mittal, MD; et al.
JAMA Dermatol. Published online December 23, 2014. doi:10.1001/jamadermatol.2014.3674

JAMA Dermatology | 
Case Report/Case Series | 
Tomoko Nakahara, MD; Atsushi Takagi, MD, PhD; Jun Yamagami, MD, PhD; et al.
JAMA Dermatol. 2014;150(12):1327-1330. doi:10.1001/jamadermatol.2014.411.
Includes: Supplemental Content

JAMA Dermatology | 
Case Report/Case Series | 
Christoph T. Ellebrecht, MD; Eun J. Choi, BS; David M. Allman, PhD; et al.
JAMA Dermatol. 2014;150(12):1331-1335. doi:10.1001/jamadermatol.2014.1939.
Includes: Supplemental Content

JAMA Dermatology | 
JAMA Dermatology Clinicopathological Challenge | 
Jake E. Turrentine, MD; Olayemi Sokumbi, MD; Nnenna G. Agim, MD
JAMA Dermatol. 2014;150(11):1223-1224. doi:10.1001/jamadermatol.2014.2087.

JAMA Dermatology | 
Case Report/Case Series |  ONLINE FIRST
Saskia Ingen-Housz-Oro, MD; Laurence Valeyrie-Allanore, MD; Anne Cosnes, MD; et al.
JAMA Dermatol. Published online October 29, 2014. doi:10.1001/jamadermatol.2014.2421

JAMA Dermatology | 
Original Investigation | 
Kara Heelan, MB, BCh, BAO, MRCPI; Faisal Al-Mohammedi, MD, FRCPC; Myles J. Smith, MB, BCh, BAO, FRCSI; et al.
JAMA Dermatol. 2014;150(7):703-708. doi:10.1001/jamadermatol.2013.6739.
Includes: Supplemental Content

JAMA Dermatology | 
JAMA Dermatology Patient Page |  FREE
Marcel F. Jonkman, MD, PhD
JAMA Dermatol. 2014;150(6):680. doi:10.1001/jamadermatol.2014.136.

JAMA Dermatology | 
Editorial | 
Dédée F. Murrell, MA, BMBCh, MD, FACD; Masayuki Amagai, MD; Victoria P. Werth, MD
JAMA Dermatol. 2014;150(3):245-247. doi:10.1001/jamadermatol.2013.8179.

JAMA Dermatology | 
Original Investigation | 
Ziba Rahbar, MD, MPH; Maryam Daneshpazhooh, MD; Mostafa Mirshams-Shahshahani, MD; et al.
JAMA Dermatol. 2014;150(3):266-272. doi:10.1001/jamadermatol.2013.8175.
Includes: Supplemental Content
Sign in to download this free article PDF

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Dermatology
JAMA Dermatology Clinicopathological Challenge  | 
Polymorphic Blistering Eruption and Stomatitis in a Patient With Non-Hodgkin Lymphoma
Tahmina Mahmood, BS; Mary Horner, MD; Alan Menter, MD
JAMA Dermatology
Case Report/Case Series  | 
Intralesional Rituximab in the Treatment of Refractory Oral Pemphigus Vulgaris
Keshavamurthy Vinay, MD; Amrinder J. Kanwar, MD, FRCP; Ankit Mittal, MD; et al.
JAMA Dermatology
Case Report/Case Series  | 
High Anti–Desmoglein 3 Antibody ELISA Index and Negative Indirect Immunofluorescence Result in a Patient With Pemphigus Vulgaris in Remission:  Evaluation of the Antibody Profile by Newly Developed Methods
Tomoko Nakahara, MD; Atsushi Takagi, MD, PhD; Jun Yamagami, MD, PhD; et al.
JAMA Dermatology
Case Report/Case Series  | 
Subcutaneous Veltuzumab, a Humanized Anti-CD20 Antibody, in the Treatment of Refractory Pemphigus Vulgaris
Christoph T. Ellebrecht, MD; Eun J. Choi, BS; David M. Allman, PhD; et al.